by US Medical Innovations | May 7, 2024 | 2024 press Release, Press Release
US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasma™...
by US Medical Innovations | Sep 22, 2023 | 2023 Press Release, Press Release
USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024 TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced and Biological Technological Sciences...
by US Medical Innovations | Aug 2, 2023 | 2023 Press Release, Press Release
Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers” The First Cold Atmospheric Plasma Phase 1 Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer TAKOMA PARK, Md.–(BUSINESS...
by US Medical Innovations | Jun 29, 2023 | 2023 Press Release, Press Release
USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™ TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC, announced today it has...
by US Medical Innovations | Jun 15, 2023 | 2023 Press Release, Press Release
JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors TAKOMA PARK, Md.–(BUSINESS WIRE)—June 15, 2023 – The Jerome Canady Research...
by US Medical Innovations | Sep 21, 2022 | 2022 Press Release, Press Release
2022 US Medical Innovations Raises $10.2 M in Private Placement TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, announced today it has secured a $10.2 million private placement deal from...
